FRT
41
-2
DTE
43
5
CVX
43
-3
ADM
28
3
YUM
43
-6
CB
57
2
CTSH
60
-3
UPS
48
2
ICE
59
-3
WMT
56
-4
DAL
84
-3
JNJ
41
3
MAS
52
-4
DHR
32
-6
V
64
-2
KR
36
-6
INTC
41
4
KHC
9
-4
GIS
22
-4
HSY
31
-6
FRT
41
-2
DTE
43
5
CVX
43
-3
ADM
28
3
YUM
43
-6
CB
57
2
CTSH
60
-3
UPS
48
2
ICE
59
-3
WMT
56
-4
DAL
84
-3
JNJ
41
3
MAS
52
-4
DHR
32
-6
V
64
-2
KR
36
-6
INTC
41
4
KHC
9
-4
GIS
22
-4
HSY
31
-6
Financhill
Back

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Vs. Neurogene Industry Stock Comparison

Sell
50

PDN
Invesco FTSE RAFI Dev Mkts ex-US S/M ETF

Last Price:
32.10
Seasonality Move:
0.9%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
50
Invesco FTSE RAFI Dev Mkts ex-US S/M ETF (PDN) is a Sell

Is Invesco FTSE RAFI Dev Mkts ex-US S/M ETF a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI Dev Mkts ex-US S/M ETF [PDN] share price is $32.09. The Score for PDN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • PDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PDN Stock Price Chart

What is Invesco FTSE RAFI Dev Mkts ex-US S/M ETF's stock price today?

  • The Invesco FTSE RAFI Dev Mkts ex-US S/M ETF share price today is $32.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDN is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

PDN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.11 Sell
Chaikin Money Flow: -759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.54 - 33.76) Sell
Bollinger Bands (100): (32.71 - 34.47) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

PDN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.58 Sell
20-day SMA: 32.92 Sell
50-day SMA: 33.87 Sell
200-day SMA: 33.06 Sell
8-day EMA: 32.46 Sell
20-day EMA: 32.93 Sell
50-day EMA: 33.43 Sell
200-day EMA: 33.01 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Earnings Growth & PDN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Invesco FTSE RAFI Dev Mkts ex-US S/M ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):